Efficacy and safety of intermittent versus continuous dose apatinib plus docetaxel as second-line therapy in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma: a randomized controlled study
间歇给药与持续给药阿帕替尼联合多西他赛作为晚期胃癌或胃食管交界处腺癌患者二线治疗的疗效和安全性:一项随机对照研究
期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-22-546
Yan, Ying; Li, Huimin; Wu, Shusheng; Wang, Gang; Luo, Huiqin; Niu, Jiayu; Cao, Lulu; Hu, Xiaoxiu; Xu, Huijun; Jia, Wei; Sun, Yubei; Yao, Yiwei; Chen, Wenju; Ke, Lihong; Hu, Bing; Ji, Chushu; Sun, Yancai; Chen, Jian; Li, Mengge; He, Yifu